miR-137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6. (Q39239384)

10 September 2017

title

miR-137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6. (English)

1 reference

10 September 2017

1 reference

Xiaolan Zhu

1

1 reference

10 September 2017

Yuefeng Li

2

1 reference

10 September 2017

Huiling Shen

3

1 reference

10 September 2017

Hao Li

4

1 reference

10 September 2017

Lulu Long

5

1 reference

10 September 2017

Lulu Hui

6

1 reference

10 September 2017

Wenlin Xu

7

1 reference

10 September 2017

language of work or name

English

0 references

publication date

21 November 2012

1 reference

10 September 2017

1 reference

10 September 2017

volume

587

1 reference

10 September 2017

issue

1

1 reference

10 September 2017

page(s)

73-81

1 reference

10 September 2017

cites work

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

MicroRNAs silence gene expression by repressing protein expression and/or by promoting mRNA decay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

miR-137 is frequently down-regulated in gastric cancer and is a negative regulator of Cdc42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

MicroRNA-137 targets carboxyl-terminal binding protein 1 in melanoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

MicroRNA-137 promoter methylation in oral rinses from patients with squamous cell carcinoma of the head and neck is associated with gender and body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

miRNA expression profiling of lung adenocarcinomas: correlation with mutational status

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

N-α-acetyltransferase 10 protein suppresses cancer cell metastasis by binding PIX proteins and inhibiting Cdc42/Rac1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

Growth and motility inhibition of breast cancer cells by epidermal growth factor receptor degradation is correlated with inactivation of Cdc42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

Raf-MEK-Erk cascade in anoikis is controlled by Rac1 and Cdc42 via Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

Selectivity and potency of cyclin-dependent kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

Expression of p19INK4d, CDK4, CDK6 in glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

Activation of cyclin D1-related kinase in human lung adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

Cell cycle activation in postmitotic neurons is essential for DNA repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

miR-181a sensitizes a multidrug-resistant leukemia cell line K562/A02 to daunorubicin by targeting BCL-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

The let-7 microRNA reduces tumor growth in mouse models of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

From cell cycle to differentiation: an expanding role for cdk6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

Rho GTPases as key transducers of proliferative signals in g1 cell cycle regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

Dysfunctions associated with methylation, microRNA expression and gene expression in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

Potentially functional polymorphisms in cell cycle genes and the survival of non-small cell lung cancer in a Chinese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

Cyclin-dependent kinase 4/6 activity is a critical determinant of pre-replication complex assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

Genes associated with early development, apoptosis and cell cycle regulation define a gene expression profile of adenoid cystic carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.004

10.1016/J.FEBSLET.2012.11.004

21 January 2018

Identifiers

DOI

1 reference

10 September 2017

1 reference